Pronađeno: 11-20 / 51 radova

Autori: Savic Aleksandar D

>> Filter: Samo Article i Review

Naslov Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry (Article)
Autori Hoeks Marlijn  ...  Savic Aleksandar D  ...  (broj koautora 32) 
Info HAEMATOLOGICA, (2020), vol. 105 br. 3, str. 640-651
Projekat Novartis Pharmacy B.V. Oncology Europe; Amgen Limited; European Union (EU) [634789]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes (Article)
Autori De Swart Louise  ...  Savic Aleksandar D  ...  (broj koautora 29) 
Info HAEMATOLOGICA, (2020), vol. 105 br. 3, str. 632-639
Projekat Novartis Pharmacy B.V. Oncology Europe; Amgen Limited; European Union (EU) [634789]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes (Article)
Autori Itzykson Raphael  ...  Savic Aleksandar D  ...  (broj koautora 27) 
Info BLOOD ADVANCES, (2018), vol. 2 br. 16, str. 2079-2089
Projekat Novartis Pharmacy B.V. Oncology Europe; Amgen Limited; European Union's Horizon 2020 research and innovation programme [634789]; Associazione Italiana per la Ricerca sul CancroAssociazione Italiana per la Ricerca sul Cancro (AIRC) [IG 20125]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study (Article)
Autori Stauder R  ...  Savic Aleksandar D  ...  (broj koautora 25) 
Info LEUKEMIA, (2018), vol. 32 br. 6, str. 1380-1392
Projekat Novartis Pharmacy B.V. Oncology Europe; Horizon 2020 research and innovation program [634789, PHC-2014-634789]; Translational Implementation of genetic evidence in the management of MDS (TRIAGE-MDS) (TRIAGE-MDS, Austrian Science Found) within the TRANSCAN
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS (Article)
Autori De Swart Louise  ...  Savic Aleksandar D  ...  (broj koautora 29) 
Info LEUKEMIA RESEARCH, (2018), vol. 67 br. , str. 21-26
Projekat Novartis Pharmacy B.V. Oncology Europe
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Impact of Red Blood Cell Transfusions on Survival in Lower-Risk MDS Patients Included in the European Leukemianet MDS (EUMDS) Registry (Meeting Abstract)
Autori De Swart Louise  ...  Savic Aleksandar D  ...  (broj koautora 20) 
Info LEUKEMIA RESEARCH, (2017), vol. 55 br. , Suppl. 1, str. S160-S161
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Health-Relatedqualityof Life Is Substantially Impaired in Lower-Risk Mds When Compared with Reference Populations and Significantly Affects Overall Survival (Meeting Abstract)
Autori Stauder R  ...  Savic Aleksandar D  ...  (broj koautora 20) 
Info LEUKEMIA RESEARCH, (2017), vol. 55 br. , Suppl. 1, str. S12-S12
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Prognostic Value of Early Drop in Platelets in Lower-Risk MDS. a Sub-Study from the European Leukemianet Lower-Risk MDS (EUMDS) Registry (Meeting Abstract)
Autori Itzykson Raphael  ...  Savic Aleksandar D  ...  (broj koautora 20) 
Info LEUKEMIA RESEARCH, (2017), vol. 55 br. , Suppl. 1, str. S10-S11
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Costs of Multiple Myeloma Management and Treatment for Elderly Patients Who Are Not Transplant Candidates in the Serbian Health Care System (Meeting Abstract)
Autori Vukicevic D  Rochau Ursula  Savic Aleksandar D  Jevdjevic M  Buchberger M  Sroczynski G  Siebert Uwe 
Info VALUE IN HEALTH, (2016), vol. 19 br. 7, str. A582-A582
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Impact of Treatment with Iron Chelators in Lower-Risk MDS Patients Participating in the European Leukemianet MDS (EUMDS) Registry (Meeting Abstract)
Autori Langemeijer Saskia  ...  Savic Aleksandar D  ...  (broj koautora 26) 
Info BLOOD, (2016), vol. 128 br. 22, str. -
Projekat Celgene; JanssenJohnson & Johnson USAJanssen Biotech Inc; Novartis; Astex; Teva
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX